Financials iZafe Group AB

Equities

IZAFE B

SE0003656834

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm 06:17:13 2024-05-08 am EDT 5-day change 1st Jan Change
0.222 SEK -2.20% Intraday chart for iZafe Group AB +0.91% -22.92%

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 138.6 87.71 51.39 97.32 57.33 24.14
Enterprise Value (EV) 1 135.6 107.5 54.86 95.52 43.59 26.44
P/E ratio -33.1 x -7 x -1.98 x -7.52 x -1.03 x -0.99 x
Yield - - - - - -
Capitalization / Revenue 894 x 11.6 x 3.59 x 10.9 x 153 x 33.1 x
EV / Revenue 875 x 14.2 x 3.83 x 10.7 x 116 x 36.3 x
EV / EBITDA -35.5 x -10.6 x -2.61 x -3.68 x -1.31 x -1.15 x
EV / FCF -16.8 x -6.38 x -3.75 x -3.51 x -2.69 x -1.95 x
FCF Yield -5.96% -15.7% -26.6% -28.5% -37.2% -51.3%
Price to Book 12.6 x 8.78 x 1.81 x 3.31 x 1.41 x 1.15 x
Nbr of stocks (in thousands) 11,692 14,449 22,297 32,769 70,871 82,947
Reference price 2 11.85 6.070 2.305 2.970 0.8090 0.2910
Announcement Date 4/6/18 4/3/19 5/25/20 5/6/21 4/8/22 4/5/23
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 0.155 7.571 14.33 8.904 0.375 0.729
EBITDA 1 -3.82 -10.17 -21.06 -25.96 -33.23 -22.98
EBIT 1 -4.238 -10.74 -22.03 -26.68 -33.27 -23.12
Operating Margin -2,734.19% -141.84% -153.73% -299.64% -8,873.07% -3,171.88%
Earnings before Tax (EBT) 1 -4.269 -11.13 -23.2 -12.84 -36.28 -23.59
Net income 1 -4.269 -11.31 -23.12 -12.75 -36.28 -23.53
Net margin -2,754.19% -149.41% -161.33% -143.24% -9,673.33% -3,227.16%
EPS 2 -0.3582 -0.8673 -1.164 -0.3949 -0.7843 -0.2942
Free Cash Flow 1 -8.088 -16.85 -14.62 -27.19 -16.2 -13.55
FCF margin -5,218.15% -222.6% -102.02% -305.39% -4,320.93% -1,858.8%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/6/18 4/3/19 5/25/20 5/6/21 4/8/22 4/5/23
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - 19.8 3.47 - - 2.3
Net Cash position 1 2.91 - - 1.8 13.7 -
Leverage (Debt/EBITDA) - -1.944 x -0.1648 x - - -0.1 x
Free Cash Flow 1 -8.09 -16.9 -14.6 -27.2 -16.2 -13.6
ROE (net income / shareholders' equity) -51.4% -106% -98.3% -38.4% -103% -59%
ROA (Net income/ Total Assets) -24.3% -23.4% -23.9% -31.2% -49.8% -29.2%
Assets 1 17.57 48.28 96.83 40.86 72.83 80.69
Book Value Per Share 2 0.9400 0.6900 1.280 0.9000 0.5700 0.2500
Cash Flow per Share 2 0.3000 0.0800 0.2600 0.0800 0.2600 0.0100
Capex - 1.66 1.23 0.72 0.21 -
Capex / Sales - 21.93% 8.58% 8.03% 57.07% -
Announcement Date 4/6/18 4/3/19 5/25/20 5/6/21 4/8/22 4/5/23
1SEK in Million2SEK
Estimates
  1. Stock Market
  2. Equities
  3. IZAFE B Stock
  4. Financials iZafe Group AB
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW